Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part I.
Boyle
B A
BA
Department of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D016481:Helicobacter Infections / Q000188:drug therapy / Q000209:etiology; D016480:Helicobacter pylori; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D019469:Indinavir / Q000009:adverse effects; D011788:Quality of Life; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019469:Indinavir